Cytokinetics Inc. buy Royal Bank of Canada
Start price
21.01.26
/
50%
€54.00
Target price
21.01.27
€81.00
Performance (%)
39.37%
Price
19:11
€75.26
Summary
This prediction is currently active. With a performance of 39.37% the BUY prediction by Royal_Bank_of_Canada is a big success. This prediction currently runs until 21.01.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cytokinetics Inc. | 5.079% | 5.079% |
| iShares Core DAX® | -1.358% | -2.165% |
| iShares Nasdaq 100 | -3.700% | -1.162% |
| iShares Nikkei 225® | -2.512% | 7.930% |
| iShares S&P 500 | -1.662% | -0.698% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics (NASDAQ:CYTK) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada. They now have a $95.00 price target on the stock.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€29.40
07.05.25
07.05.25
€70.52
07.05.26
07.05.26
112.86%
08.05.26
08.05.26
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€45.80
18.12.24
18.12.24
€78.17
18.12.25
18.12.25
14.63%
19.12.25
19.12.25